New York, NY USA

Our News on Newswise

Study Reveals Mechanisms Cancer Cells Use to Establish Metastatic Brain Tumors


New research from Memorial Sloan Kettering provides fresh insight into the biologic mechanisms that individual cancer cells use to metastasize to the brain.
2/27/2014 12:00 PM EST

Memorial Sloan Kettering Appoints Pereira & O’Dell New York as Creative Agency of Record, Media Storm as Media Agency of Record

Memorial Sloan Kettering announced the appointment of Pereira & O’Dell in New York as its creative agency of record and Media Storm as its media agency of record.
2/25/2014 9:05 AM EST

Cell Therapy Shows Remarkable Ability to Eradicate Cancer in Clinical Study

The largest clinical study ever conducted to date of patients with advanced leukemia found that 88 percent achieved complete remissions after being treated with genetically modified versions of their own immune cells.
2/19/2014 2:00 PM EST

Newly Engineered Monoclonal Antibody Shows Promise, Moves Toward Clinical Testing

Memorial Sloan Kettering Cancer Center and Eureka Therapeutics recently entered into a licensing agreement with Novartis to develop a unique monoclonal antibody.
1/28/2014 12:00 PM EST

Memorial Sloan-Kettering Cancer Center Shares $540 Million in New Funding From Ludwig Cancer Research

Memorial Sloan-Kettering Cancer Center, along with five other elite academic institutions, will share an unprecedented total of $540 million in new financial support from Ludwig Cancer Research.
1/6/2014 7:00 AM EST

Accomplished Scientist and Entrepreneur Selected to Lead Tri-Institutional Therapeutics Discovery Institute


Michael A. Foley, PhD, has been selected to lead the Tri-Institutional Therapeutics Discovery Institute, Inc. (Tri-I TDI), a pioneering collaboration of Weill Cornell Medical College, The Rockefeller University and Memorial Sloan-Kettering Cancer...
12/2/2013 3:00 PM EST

New Position Created to Oversee Memorial Sloan-Kettering’s Regional Care Network and Alliance


Memorial Sloan-Kettering Cancer Center has announced the appointment of surgical oncologist Richard Barakat to the new position of Deputy Physician-in-Chief for the Memorial Sloan-Kettering Regional Care Network and Alliance.
10/17/2013 2:00 PM EDT

Tri-Institutional Therapeutics Discovery Institute, Inc. Launched by Memorial Sloan-Kettering Cancer Center, The Rockefeller University and Weill Cornell Medical College, and Partnership Formed with Takeda

Memorial Sloan-Kettering Cancer Center, The Rockefeller University and Weill Cornell Medical College have formed the pioneering Tri-Institutional Therapeutics Discovery Institute, Inc. and have partnered with Takeda Pharmaceutical Company, Ltd.
10/1/2013 11:00 AM EDT

Our YouTube Videos